The Academy believes that the existence, methods and results of clinical and health research involving patients - whether positive or negative - should be made swiftly available for patient, social and scientific benefit.
In 2012, the Academy responded to a consultation from the Medicine and Healthcare product Regulatory Agency regarding an 'Early Access to Medicines Scheme' that aims to 'bring access to certain new medicines before they are formally licensed'.
The Academy of Medical Sciences has worked to outline the benefits of stratified approaches to medicine, and to address barriers to their widespread development and adoption.
The Academy, the Medical Research Council and Wellcome Trust established the UK Evaluation Forum to explore how organisations might evaluate and demonstrate the outcomes of research relevant to human health.
The Academy responded to the triennial review of the research councils, which is considering structures for the delivery of the public funding of research.